Genflow Biosciences PLC Announces Notification of Major Holdings

LONDON, UK / ACCESSWIRE / April 10, 2024 / TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BP2C3V08

Issuer Name

GENFLOW BIOSCIENCES PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Premier Miton Group plc

City of registered office (if applicable)

GUILDFORD

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

09-Apr-2024

6. Date on which Issuer notified

09-Apr-2024

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	9.150527	0.000000	9.150527	32000000
Position of previous notification (if applicable)	N/A		N/A

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BP2C3V08		32000000		9.150527
Sub Total 8.A	32000000		9.150527%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Premier Miton Group plc	Premier Miton Group Plc (Chain 1)
Premier Miton Group plc	Premier Asset Management Midco Ltd (Chain 1)
Premier Miton Group plc	Premier Asset Management Holdings Ltd (Chain 1)
Premier Miton Group plc	Premier Asset Management Limited (Chain 1)
Premier Miton Group plc	Premier Investment Group Ltd (Chain 1)
Premier Miton Group plc	Premier Fund Managers Ltd (Chain 1)	9.150527		9.150527%
Premier Miton Group plc	Premier Miton Group Plc (Chain 2)
Premier Miton Group plc	Premier Asset Management Midco Ltd (Chain 2)
Premier Miton Group plc	Tellworth Investments LLP (Chain 2)

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

09-Apr-2024

13. Place Of Completion

Guildford, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

SOURCE: Genflow Biosciences PLC

View the original press release on accesswire.com


The Genflow Biosciences Stock at the time of publication of the news with a fall of -1,76 % to 0,017GBP on London stock exchange (10. April 2024, 14:34 Uhr).